171 related articles for article (PubMed ID: 22709368)
21. A Novel Likely Pathogenic Variant in the
Boeckelmann D; Wolter M; Käsmann-Kellner B; Koehler U; Schieber-Nakamura L; Zieger B
Cells; 2021 Oct; 10(10):. PubMed ID: 34685610
[TBL] [Abstract][Full Text] [Related]
22. A divalent interaction between HPS1 and HPS4 is required for the formation of the biogenesis of lysosome-related organelle complex-3 (BLOC-3).
Carmona-Rivera C; Simeonov DR; Cardillo ND; Gahl WA; Cadilla CL
Biochim Biophys Acta; 2013 Mar; 1833(3):468-78. PubMed ID: 23103514
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants associated with Hermansky-Pudlak syndrome.
Merideth MA; Introne WJ; Wang JA; O'Brien KJ; Huizing M; Gochuico BR
Platelets; 2020 May; 31(4):544-547. PubMed ID: 32436471
[TBL] [Abstract][Full Text] [Related]
24. A novel mutation in a Turkish patient with Hermansky-Pudlak syndrome type 5.
Korswagen LA; Huizing M; Simsek S; Janssen JJ; Zweegman S
Eur J Haematol; 2008 Apr; 80(4):356-60. PubMed ID: 18182080
[TBL] [Abstract][Full Text] [Related]
25. Genetic variants and mutational spectrum of Chinese Hermansky-Pudlak syndrome patients.
Liu T; Yuan Y; Bai D; Qi Z; Yang L; Zhang T; Yang X; Li W; Wei A
Pigment Cell Melanoma Res; 2021 Jan; 34(1):111-121. PubMed ID: 32725903
[TBL] [Abstract][Full Text] [Related]
26. NGS-based 100-gene panel of hypopigmentation identifies mutations in Chinese Hermansky-Pudlak syndrome patients.
Wei A; Yuan Y; Bai D; Ma J; Hao Z; Zhang Y; Yu J; Zhou Z; Yang L; Yang X; Li L; Li W
Pigment Cell Melanoma Res; 2016 Nov; 29(6):702-706. PubMed ID: 27593200
[TBL] [Abstract][Full Text] [Related]
27. An immunoblotting assay to facilitate the molecular diagnosis of Hermansky-Pudlak syndrome.
Nazarian R; Huizing M; Helip-Wooley A; Starcevic M; Gahl WA; Dell'Angelica EC
Mol Genet Metab; 2008 Feb; 93(2):134-44. PubMed ID: 17933573
[TBL] [Abstract][Full Text] [Related]
28. Nonsense mutations in ADTB3A cause complete deficiency of the beta3A subunit of adaptor complex-3 and severe Hermansky-Pudlak syndrome type 2.
Huizing M; Scher CD; Strovel E; Fitzpatrick DL; Hartnell LM; Anikster Y; Gahl WA
Pediatr Res; 2002 Feb; 51(2):150-8. PubMed ID: 11809908
[TBL] [Abstract][Full Text] [Related]
29. Hermansky-Pudlak syndrome type 1 in patients of Indian descent.
Vincent LM; Adams D; Hess RA; Ziegler SG; Tsilou E; Golas G; O'Brien KJ; White JG; Huizing M; Gahl WA
Mol Genet Metab; 2009 Jul; 97(3):227-33. PubMed ID: 19398212
[TBL] [Abstract][Full Text] [Related]
30. Hermansky-Pudlak syndrome subtype 5 (HPS-5) novel mutation in a 65 year-old with oculocutaneous hypopigmentation and mild bleeding diathesis: The importance of recognizing a subtle phenotype.
Botero JP; Chen D; Majerus JA; Coon LM; He R; Warad DM; Pruthi RK; Nichols WL
Platelets; 2018 Jan; 29(1):91-94. PubMed ID: 29090612
[TBL] [Abstract][Full Text] [Related]
31. Exome sequencing identifies SLC24A5 as a candidate gene for nonsyndromic oculocutaneous albinism.
Wei AH; Zang DJ; Zhang Z; Liu XZ; He X; Yang L; Wang Y; Zhou ZY; Zhang MR; Dai LL; Yang XM; Li W
J Invest Dermatol; 2013 Jul; 133(7):1834-40. PubMed ID: 23364476
[TBL] [Abstract][Full Text] [Related]
32. Hermansky-Pudlak syndrome: Mutation update.
Huizing M; Malicdan MCV; Wang JA; Pri-Chen H; Hess RA; Fischer R; O'Brien KJ; Merideth MA; Gahl WA; Gochuico BR
Hum Mutat; 2020 Mar; 41(3):543-580. PubMed ID: 31898847
[TBL] [Abstract][Full Text] [Related]
33. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico.
Santiago Borrero PJ; Rodríguez-Pérez Y; Renta JY; Izquierdo NJ; Del Fierro L; Muñoz D; Molina NL; Ramírez S; Pagán-Mercado G; Ortíz I; Rivera-Caragol E; Spritz RA; Cadilla CL
J Invest Dermatol; 2006 Jan; 126(1):85-90. PubMed ID: 16417222
[TBL] [Abstract][Full Text] [Related]
34. snow white, a zebrafish model of Hermansky-Pudlak Syndrome type 5.
Daly CM; Willer J; Gregg R; Gross JM
Genetics; 2013 Oct; 195(2):481-94. PubMed ID: 23893484
[TBL] [Abstract][Full Text] [Related]
35. Hermansky-Pudlak syndrome type 1: gene organization, novel mutations, and clinical-molecular review of non-Puerto Rican cases.
Hermos CR; Huizing M; Kaiser-Kupfer MI; Gahl WA
Hum Mutat; 2002 Dec; 20(6):482. PubMed ID: 12442288
[TBL] [Abstract][Full Text] [Related]
36. Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function.
Wei ML
Pigment Cell Res; 2006 Feb; 19(1):19-42. PubMed ID: 16420244
[TBL] [Abstract][Full Text] [Related]
37. New insights into the pathogenesis of Hermansky-Pudlak syndrome.
Li W; Hao CJ; Hao ZH; Ma J; Wang QC; Yuan YF; Gong JJ; Chen YY; Yu JY; Wei AH
Pigment Cell Melanoma Res; 2022 May; 35(3):290-302. PubMed ID: 35129281
[TBL] [Abstract][Full Text] [Related]
38. BLOC1S5 pathogenic variants cause a new type of Hermansky-Pudlak syndrome.
Pennamen P; Le L; Tingaud-Sequeira A; Fiore M; Bauters A; Van Duong Béatrice N; Coste V; Bordet JC; Plaisant C; Diallo M; Michaud V; Trimouille A; Lacombe D; Lasseaux E; Delevoye C; Picard FM; Delobel B; Marks MS; Arveiler B
Genet Med; 2020 Oct; 22(10):1613-1622. PubMed ID: 32565547
[TBL] [Abstract][Full Text] [Related]
39. Novel mutation in two brothers with Hermansky Pudlak syndrome type 3.
Sandrock-Lang K; Bartsch I; Buechele N; Koehler U; Simon-Gabriel CP; Eckenweiler M; Zieger B
Blood Cells Mol Dis; 2017 Sep; 67():75-80. PubMed ID: 28284561
[TBL] [Abstract][Full Text] [Related]
40. Biogenesis of lysosome-related organelles complex 3 (BLOC-3): a complex containing the Hermansky-Pudlak syndrome (HPS) proteins HPS1 and HPS4.
Nazarian R; Falcón-Pérez JM; Dell'Angelica EC
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8770-5. PubMed ID: 12847290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
